Organon To Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Organon (NYSE: OGN) will participate in the 41st Annual J.P. Morgan Healthcare Conference on January 10th, 2023, at 7:30 a.m. PT. CEO Kevin Ali and CFO Matthew Walsh will engage in a fireside chat, accessible via a live audio webcast. This event underscores Organon's commitment to women's health with over 60 products aimed at improving health outcomes. The company, headquartered in Jersey City, New Jersey, is focused on innovation and collaboration in the biopharmaceutical sector.

JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at the 41^st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10th, 2023 at 7:30 a.m. PT.

Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at https://jpmorgan.metameetings.net/events/healthcare23/sessions/43878-organon/webcast?gpu_only=true&kiosk=true.

About Organon

Organon is a global healthcare company formed to focus on improving the health of women throughout their lives. Organon has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the women’s health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in innovation and future growth opportunities in women’s health. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets.

Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 10,000 employees with headquarters located in Jersey City, New Jersey.

For more information, visit http://www.organon.com and connect with us on LinkedIn and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221215005137/en/

Media Contacts:

Karissa Peer

(614) 314-8094

Kate Vossen

(732) 675-8448

Investor Contacts:

Jennifer Halchak

(201) 275-2711

Alex Arzeno

(646) 430-2028

Source: Organon & Co.

FAQ

When is Organon participating in the J.P. Morgan Healthcare Conference?

Organon will participate in the J.P. Morgan Healthcare Conference on January 10th, 2023, at 7:30 a.m. PT.

Who will represent Organon at the J.P. Morgan Healthcare Conference?

CEO Kevin Ali and CFO Matthew Walsh will represent Organon at the conference.

How can I listen to Organon's presentation at the conference?

You can listen to Organon's presentation via a live audio webcast available at the J.P. Morgan Healthcare Conference's official site.

What is Organon's focus in the healthcare market?

Organon focuses on improving women's health and has a portfolio of over 60 medicines across several therapeutic areas.

What is the stock symbol for Organon?

The stock symbol for Organon is OGN.